Ein Medikamenten-Cocktail aus #Interferon_beta1b, #Lopinavir_Ritonavir und #Ribavirin soll laut einer im The Lancet veröffentlichten Studie erste Erfolge bei Patienten mit einem milden bis moderaten #Covid_19 Verlauf zeigen. https://t.co/3szsCPAPfb
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @lucavalenti75: back to ifn+rbv?
RT @EricTopol: Very encouraging randomized trial results for interferon β-1b in mild to moderate #COVID19: marked reduction viral shedding,…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @internistaneumo: interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients with COVID-19 🙈
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
رابط الدراسة https://t.co/W7QMBM5lqi
RT @EricTopol: Very encouraging randomized trial results for interferon β-1b in mild to moderate #COVID19: marked reduction viral shedding,…
RT @ABsteward: Early combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin was safe and superior to lopinavir–ritonavir alo…
RT @jorroser: Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opcione…
RT @internistaneumo: interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients with COVID-19 🙈
RT @internistaneumo: interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients with COVID-19 🙈 https://t.co/k2aFu…
interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients with COVID-19 🙈
Hey @ScottAdamsSays this is an interesting read. Head to the results and discussions sections for the good stuff.
RT @EricTopol: Links and details for the 2 published trials https://t.co/OBWzhQrLPt https://t.co/AydJFDFGFF
2/2 Patients on cocktail stopped shedding #coronavirus sooner, researchers found. Cocktail of 3 antivirals: lopinavir-ritonavir (Kaletra); ribavirin, used to treat hepatitis C; interferon beta-1b, used to treat multiple sclerosis. https://t.co/3k0ZjXDL
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @INERsticio: We must change our strategy to treat COVID19 We propose the sooner the better. https://t.co/8zLk9mge2j
RT @kensou55: インターフェロンβ追加でCOVID-19患者の予後改善。 糖尿病患者で予後不良なのは、高血糖で肝臓でのIFNβ産生が低下することも関与する可能性が示唆されている。 https://t.co/KhIQCsQsFG
RT @nathanpsmad: 🔥Interesting #RCT for #COVID19 #SARS_CoV_2 Interferon beta-1b, lopinavir–ritonavir, ribavirin in MILD patients (0 death,…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @INERsticio: We must change our strategy to treat COVID19 We propose the sooner the better. https://t.co/8zLk9mge2j
インターフェロンβ追加でCOVID-19患者の予後改善。 糖尿病患者で予後不良なのは、高血糖で肝臓でのIFNβ産生が低下することも関与する可能性が示唆されている。 https://t.co/KhIQCsQsFG
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @emlitofnote: "The primary endpoint was time to achieve a negative RT-PCR result for SARS-CoV-2." ... why not a patient-oriented outcom…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @MonsieurQFB: Entre buenas noticias, el estudio de la combinación triple de interferon beta-1b, lopinavir–ritonavir, y ribavirin ha dado…
RT @srrezaie: Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alle…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
Triple therapy with interferon beta-1b, lopinavir-ritonavir, & ribavirin used early in illness shortened virus shedding, alleviation of sxs, & correlated with faster DC of pts with mild to mod #COVID19 (Unclear pt oriented outcomes) https://t.co/L
RT @Globalbiosec: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hos…
RT @gorka_orive: Un ensayo clínico demuestra que la combinación de interferon beta-1b, lopinavir–ritonavir, y ribavirina en el tratamiento…
RT @Globalbiosec: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hos…
„Early triple antiviral therapy was safe and superior to lopinavir–ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19.“
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @samgandy: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospita…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/a1lI2mi69K
RT @segawashin: COVID19患者に対する治験。lopinavirとritonavir単独の場合と、これに加えてribavirinとインターフェロン投与群を二重盲検、後者のほうが複数箇所のサンプルでウイルス減少が有意に顕著だった……ということみたい。香港のグルー…
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @nathanpsmad: 🔥Interesting #RCT for #COVID19 #SARS_CoV_2 Interferon beta-1b, lopinavir–ritonavir, ribavirin in MILD patients (0 death,…
RT @jorroser: Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opcione…
Interferon combo trial - The combination group median time from start of treatment to negative nasopharyngeal swab (7 days) versus control group (lopinavir–ritonavir alone)(12 days); [95% CI 1·86–10·24], p=0·0010). During the study no patients died. https:
RT @Transplant_Doc: Interferon-b + ribavirin + lopinavir–ritonavir was safe and superior to lopinavir–ritonavir alone in alleviating sympto…
RT @jorroser: Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opcione…
RT @ABsteward: Mild category based on NEWS score and SOFA Do you find it logical to treat mild /mod #COVID19 with this combination of 3 dru…
RT @nathanpsmad: 🔥Interesting #RCT for #COVID19 #SARS_CoV_2 Interferon beta-1b, lopinavir–ritonavir, ribavirin in MILD patients (0 death,…
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @influenzer3: ●昨日、新聞記事で紹介した3剤併用療法について →RBV+ IFN-β-1b+LPV/rの3剤併用とLPV/r単剤とのRCT。 併用群がウイルス量を有意に減らし、臨床症状を改善させ、IL-6を低下させたという結果です。 副作用がLPV/r単剤と…
@therytc Mum will want to read.
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
RT @thelonevirologi: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/q4asTonU8e
RT @andycorneys: Some good news at last & I don’t mean Johnson’s incoherent twat like bumble! https://t.co/16WUEfWkVu?
Let's hope "the science" can eventually be so compelling that life saving decisions are taken out of the hands of the self serving Boris & Co.
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @andycorneys: Some good news at last & I don’t mean Johnson’s incoherent twat like bumble! https://t.co/16WUEfWkVu?
RT @andycorneys: Some good news at last & I don’t mean Johnson’s incoherent twat like bumble! https://t.co/16WUEfWkVu?
RT @EricTopol: Very encouraging randomized trial results for interferon β-1b in mild to moderate #COVID19: marked reduction viral shedding,…
Some good news at last & I don’t mean Johnson’s incoherent twat like bumble! https://t.co/16WUEfWkVu?
RT @richardhorton1: Important early new data on combination treatment for mild-moderate COVID-19. Extremely encouraging. https://t.co/hG2ae…
RT @richardhorton1: Important early new data on combination treatment for mild-moderate COVID-19. Extremely encouraging. https://t.co/hG2ae…
I have no idea what this means, but take comfort from the fact that some people do!
RT @INERsticio: We must change our strategy to treat COVID19 We propose the sooner the better. https://t.co/8zLk9mge2j
We must change our strategy to treat COVID19 We propose the sooner the better. https://t.co/8zLk9mge2j
Meanwhile patients are getting HIV and Hep C meds https://t.co/T4wyqbNcH7
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
If it was just a flu, why are they trying HIV and Hep C meds to treat Covid-19 patients??? #TheLancet https://t.co/T4wyqbNcH7
RT @richardhorton1: Important early new data on combination treatment for mild-moderate COVID-19. Extremely encouraging.
RT @MonsieurQFB: Entre buenas noticias, el estudio de la combinación triple de interferon beta-1b, lopinavir–ritonavir, y ribavirin ha dado…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
Evidencia de que debemos replantear la terapia contra el COVID19, entre más rápido al inicio de los síntomas mejor. Opciones de tratamiento antiviral hay: remdisivir, invermectina, HQC, interferon, Ab monoclonales Hay que aprender a usarlos a tiempo. ht
RT @influenzer3: →原著はこれのようです。 まだ読んでません。 IFN-β-1b、LPV/r、RBVの3剤併用とLPV/r単剤との比較のようです。 副作用が強烈にありそうで心配ですが・・・ 明日、原著を見てみますwww https://t.co/sEm5J4KK…
RT @influenzer3: ●昨日、新聞記事で紹介した3剤併用療法について →RBV+ IFN-β-1b+LPV/rの3剤併用とLPV/r単剤とのRCT。 併用群がウイルス量を有意に減らし、臨床症状を改善させ、IL-6を低下させたという結果です。 副作用がLPV/r単剤と…
RT @MonsieurQFB: Entre buenas noticias, el estudio de la combinación triple de interferon beta-1b, lopinavir–ritonavir, y ribavirin ha dado…
RT @segawashin: COVID19患者に対する治験。lopinavirとritonavir単独の場合と、これに加えてribavirinとインターフェロン投与群を二重盲検、後者のほうが複数箇所のサンプルでウイルス減少が有意に顕著だった……ということみたい。香港のグルー…
RT @segawashin: COVID19患者に対する治験。lopinavirとritonavir単独の場合と、これに加えてribavirinとインターフェロン投与群を二重盲検、後者のほうが複数箇所のサンプルでウイルス減少が有意に顕著だった……ということみたい。香港のグルー…
@TonkaTP @tv_Amaro Por fa preguntar a algun experto https://t.co/iwHSH3nJGg
Hong Kong study: Hung et al. Lancet. IFN-beta + LPV/r + ribavirin, vs LPV/r/riba alone in mild/mod hospitalized COVID pts. https://t.co/qLw0LnzoBr BenevolentAI role in baricitinib candidacy: https://t.co/aHAMCHamNg
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. https://t.co/3ZsojCrBAM
RT @segawashin: COVID19患者に対する治験。lopinavirとritonavir単独の場合と、これに加えてribavirinとインターフェロン投与群を二重盲検、後者のほうが複数箇所のサンプルでウイルス減少が有意に顕著だった……ということみたい。香港のグルー…
RT @segawashin: COVID19患者に対する治験。lopinavirとritonavir単独の場合と、これに加えてribavirinとインターフェロン投与群を二重盲検、後者のほうが複数箇所のサンプルでウイルス減少が有意に顕著だった……ということみたい。香港のグルー…
Une trithérapie #interferon ß, #lopinavir_ritonavir et et #ribavirine pour le traitement des patients admis à l'hôpital avec #COVID_19: Résultats d'un essai clinique, randomisé, de phase 2 réalisé à #HongKong https://t.co/WgHdzsuMDT https://t.co/Z773yahZ
RT @influenzer3: ●昨日、新聞記事で紹介した3剤併用療法について →RBV+ IFN-β-1b+LPV/rの3剤併用とLPV/r単剤とのRCT。 併用群がウイルス量を有意に減らし、臨床症状を改善させ、IL-6を低下させたという結果です。 副作用がLPV/r単剤と…
RT @TheLancet: NEW Research—New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise…
RT @ABsteward: Mild category based on NEWS score and SOFA Do you find it logical to treat mild /mod #COVID19 with this combination of 3 dru…
Interesting report by Lancet about a combination of 3 drugs: The combination group had a ignificantly shorter median time from start of study treatment to negative nasopharyngeal swab No difference between the two groups in terms of side-effect. https://
RT @EricTopol: Links and details for the 2 published trials https://t.co/OBWzhQrLPt https://t.co/AydJFDFGFF
RT @Dra_TeraizaMesa: New triple antiviral drug therapy of interferon beta-1b, lopinavir-ritonavir, and ribavirin shows early promise for tr…
In God we trust
RT @influenzer3: ●昨日、新聞記事で紹介した3剤併用療法について →RBV+ IFN-β-1b+LPV/rの3剤併用とLPV/r単剤とのRCT。 併用群がウイルス量を有意に減らし、臨床症状を改善させ、IL-6を低下させたという結果です。 副作用がLPV/r単剤と…
@EmmanuelMacron Thanks, Jesus! Subject : Hong Kong made A Drug Cocktail for COVID-19! 1. The Lancet reported! https://t.co/koIBTkyFgk 2. The New York Time reported! https://t.co/IYfh8CQTP3 Big Have international space information (ISI) ltd. clkwong@! 香港鄺祖良
@AngelaMerkeICDU Thanks, Jesus! Subject : Hong Kong made A Drug Cocktail for COVID-19! 1. The Lancet reported! https://t.co/koIBTkyFgk 2. The New York Time reported! https://t.co/IYfh8CQTP3 Big Have international space information (ISI) ltd. clkwong@! 香港鄺祖